Biopharma Innovator Achieves $34.7-Million Public Offering
Biopharma Innovator Achieves $34.7-Million Public Offering
![Biopharma Innovator Achieves $34.7-Million Public Offering](/static/d83bcc52c91b4545d37798f5b395adf2/aab3c/hearing-scaled.jpg)
In what will provide a significant boost to a biopharma innovator in the field of human hearing, client Otonomy brought in $34.7 million in a recent public offering. The NASDAQ-traded company engaged in the IPO after Procopio patent attorney and PhD scientist Frank Yang performed due diligence, including a review of Otonomy’s intellectual property portfolio.
Learn more about the IPO in Otonomy’s press release.
MEDIA CONTACT
Patrick Ross, Senior Manager of Marketing & Communications
EmailP: 619.906.5740
EVENTS CONTACT
Suzie Jayyusi, Events Planner
EmailP: 619.525.3818